Trans Employment Mela applicants hope to find jobs in inclusive workplaces
The job fair, organised by the Union Ministry of Social Justice and Empowerment with two private entities, aims to introduce transgender persons and non-binary individuals to firms that are sensitised to the infrastructural requirements and policies related to transgender people.
Aarav Tawar, 26, said, 'I was forced to leave my previous job in six months as I faced discrimination and harassment due to my appearance. The fact that I was qualified did not matter as the company was non-inclusive and insensitive, and the six months I worked there were horrible.'
Zain Khan, 25, another applicant, said, 'At my previous workplace, I hid my identity to avoid facing problems. Now I'm hoping to find a job where I can grow professionally.'
Anshul, 29, hoped to find a job in a company that provides better health insurance facilities.
Pushkar, 40, vice-president (human resources) at HDFC Bank, one of the recruiters, said that hiring transgender persons 'needs adjustments from both sides'.
'Giving a job [to a transgender person] is easier, sustaining it is the challenge. It requires a gradual adjustment from both sides. The bigger challenge is creating the physical infrastructure such as separate washrooms and gender-neutral policies. So, initially, the candidates begin by working from home, and then move to the physical workplace, which gives ample time for both sides to adjust,' he said.
[Written by P. Vijaya Ramanathan]
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
SC agrees to hear HDFC CEO Sashidhar Jagdishan's appeal seeking quashing of FIR by Lilavati Trust
The Supreme Court agreed to hear on Friday HDFC Bank 's Managing Director and Chief Executive Officer Sashidhar Jagdishan 's appeal seeking quashing of a first information report (FIR) for his alleged involvement in the fraudulent activities concerning the financials of the Lilavati Kirtilal Mehta Medical Trust, which runs the Lilavati Hospital in Bandra, Mumbai. The FIR registered in May against Jagdisan on the Trust's complaint accused him of accepting Rs 2.05 crore in bribes to help the Chetan Mehta Group retain illegal and undue control over the governance of the Trust. Jagdishan is being accused of misusing his position as the head of a leading private bank to interfere in the internal affairs of a charitable organisation. Senior counsel Mukul Rohatgi, appearing for Jagdishan, on Thursday mentioned the matter before a bench led by Justice MM Sundresh for urgent hearing, saying the three benches of the Bombay High Court have recused themselves from hearing the case, thus causing a delay in the matter. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like The Top 25 Most Beautiful Women In The World Articles Vally Undo 'A frivolous FIR has been lodged against the MD and the Bank by the trustees of the Lilavati hospital, who are litigating against the other group of trustees. The bank has to recover money from them. In order to twist the arm, they have lodged an FIR through the Magistrate against the MD. We went to the Bombay High Court. Three benches of the Bombay High Court recused from hearing. Now the next date is given as July 14, that is also tentative. Every day the bank is suffering," he contended. The FIR, registered last month by the Bandra Police Station following a May 29 order by a local magistrate, booked Jagdishan and several others, including former trustee Chetan Mehta, for criminal breach of trust and cheating. The order by the Magistrate was issued after a seized cash diary allegedly showed misappropriation of Rs 14.42 crore by some of the trustees. Live Events Jagdishan, who took charge as MD and CEO of HDFC Bank in 2020, has sought the setting aside of the magistrate's order that initiated the probe. He also sought a stay on the enquiry against him and protection from any coercive action, including filing of a charge sheet, failing which he will "suffer grave loss and irreparable injury". In June, HDFC Bank had denied the allegations, saying 'HDFC Bank's MD and CEO Mr Sashidhar Jagdishan is being targeted by unscrupulous persons who are abusing the legal process to thwart the recovery of the long-outstanding loan due to the Bank from recalcitrant defaulters.'
New Indian Express
3 hours ago
- New Indian Express
HDFC Bank's Jagdishan moves SC seeking to quash Lilavati FIR
MUMBAI: Sashidhar Jagdishan, the chief executive of the largest private sector lender HDFC Bank, has moved the Supreme Court seeking to quash the FIR filed by the Lilavati Kirtilal Mehta Medical Trust alleging that he has taken a bribe of Rs 2.05 crore from one of the past trustees. The apex court will hear the matter Friday. The desperate move by Jagdishan comes after three judges of the Bombay High Court had over the past few weeks recused themselves from hearing the case citing their investments in the bank's shares or their personal associations with the both the petitioners. Also, according to an earlier administrative order by the High Court, cases related to the Lilavati Trust are not be listed before six other judges too. The FIR filed by the Lilavati Medical Trust, which runs a superspeciality hospital under the name of Lilavati Hospital in Mumbai, had accused Jagdishan of accepting a bribe of Rs 2.05 crore from an erstwhile trustee Chetan Mehta, for giving him financial advice and helping him to retain control over the Trust's governance. According to a report in LiveLaw, a website that covers legal matters, on Thursday senior advocate Mukul Rohatgi mentioned the matter before a bench of justices MM Sundresh and K Vinod Chandran and sought urgent listing of the matter Friday. Justice Sundresh, who presided over the brief hearing, directed that the matter be listed for Friday. The FIR also accuses Jagdishan of interfering in the internal affairs of the trust by misusing his position. Initially, Jagdishan's plea was listed for hearing before a HC division bench of justices Ajay Gadkari and Rajesh Patil on June 18. However, Justice Patil cited some personal difficulty and recused from hearing the matter and the court has agreed to hear the matter Friday. HDFC Bank had been refuting all the charges lelvelled by the trust and Mehta saying the bank and its senior officials are being targeted by unscrupulous persons who are abusing the legal process to thwart the recovery of the long outstanding loan due to the bank from recalcitrant defaulter- Splendour Gems (formerly known as Beautiful Diamonds), a company owned by the petitioner Mehta and had owed Rs 65.22 crore to the bank till end May.
Economic Times
8 hours ago
- Economic Times
HDB Financial shares zoom 20% from IPO price. Did GMP-hungry retail investors miss the memo?
Shares of HDFC Bank-backed HDB Financial Services surged as much as 6% on Thursday to an intraday high of Rs 891.65 on the BSE, extending their post-listing rally and taking total gains for IPO investors to 20.5% from the IPO issue price of Rs 740. But while institutional investors are now sitting on substantial paper gains, retail investors, many of whom sat out the IPO, are left watching from the sidelines, guided by signals that didn't tell the whole story. ADVERTISEMENT The stock had already delivered a 14% jump on debut Wednesday, listing at Rs 835 and closing the session at Rs 840.90, making it one of the year's most successful entries into the public market. One key reason for the retail hesitation lies in the market's obsession with grey market premiums (GMPs). GMP has become the unofficial indicator of market sentiment and investor excitement before an IPO hits the official stock exchange, but only for retail investors. For institutional investors, that is not the case. Before the listing, HDB Financial's IPO GMP hovered in the Rs 67–73 range, indicating an average potential listing pop of just 8%–9%. This modest projection, though later proven conservative, shaped retail expectations. 'Majority of the retail investors approach IPO from listing gains perspective and looking at the tepid GMPs, response would have been muted,' said Sunny Agrawal, Head of Fundamental Equity Research at SBI Securities. ADVERTISEMENT Despite the GMP ticking higher just ahead of listing, retail participation remained tepid at 1.4 times subscription, far below the institutional rush. ADVERTISEMENT Qualified Institutional Buyers (QIBs) subscribed their portion of the Rs 12,500 crore IPO 55.47 times.'Institutional investors deploy money from a long-term perspective in the business and that seems to be the case with HDB too, which is backed by the strong parentage coupled with a well-established scalable business,' Agrawal said. ADVERTISEMENT Tarun Singh, MD and Founder of Highbrow Securities, attributed the overwhelming QIB demand to HDB's 'structural advantage as a diversified, RBI-upper-layer NBFC with HDFC Bank's distribution muscle.' Singh said the 55 times institutional bid 'reflects confidence in its 'phygital' Tier 2–4 reach and 23% loan book CAGR.'Singh noted that 'what institutions are really acquiring is optionality—a call option on India's financial formalization where HDB's 1,700 branches become acquisition targets themselves when the NBFC consolidation wave hits.' He added, 'the real institutional play here is regulatory arbitrage; they're front-running RBI's forced institutionalization of shadow banking.' With a capital adequacy ratio of 16.8%, 'that's not just a number; it's a war chest to consolidate market share when smaller NBFCs inevitably get squeezed by coming regulations.' ADVERTISEMENT While the smart money looked years ahead, retail investors were stuck on near-term signals and sentiment fatigue. Singh said, 'retail investors remain wary of NBFC valuations amid margin pressures,' and pointed to 'HDFC Bank stake-sale fatigue and memories of recent IPO letdowns' as reasons for the subdued echoed similar sentiments, saying that the IPO's large size and history of muted post-listing performance in other NBFCs may have led retail investors to adopt a 'wait and watch approach.'Even analysts bullish on HDB acknowledge that the stock was no bargain. 'Let's be clear—nobody's buying this IPO for its bargain valuation. At 3.5x book, you're paying full freight for the HDFC pedigree,' Singh Asset Capital Markets said HDB's fundamentals remain robust, with an ROA of 2.2% and ROE of 14.7% in FY25, and gross NPAs at 2.26%. However, it noted that the IPO is 'fully priced given the business's fundamentals and ROE of ~15%,' though the company 'may benefit from the strong HDFC brand going forward.' Brokerage Emkay Global has initiated coverage on the newly listed stock with a 'buy' rating and a target price of Rs 900. Emkay expects a RoA of 2.7% and RoE of 17% by FY28, along with a 20% CAGR in assets under management and 27% EPS CAGR between FY25 and FY28. The brokerage cited HDB's wide customer base of 19 million, branch-heavy distribution, and focus on underserved segments as long-term strengths. HDB's rally now stands as a missed opportunity for retail investors who followed short-term signals instead of strategic cues. Singh said that 'institutions aren't just buying an NBFC, they're acquiring a strategic beachhead in India's formalizing credit economy. HDB's 1,700+ semi-urban branches represent hard infrastructure that no fintech can replicate overnight.'With HDB's post-listing momentum continuing, analysts say the IPO may become a bellwether for upcoming NBFC listings. Singh noted, 'it validates RBI's push to list large NBFCs and will embolden peers, but issuers must justify valuations with granular asset-quality disclosures to win retail.' Also read | HDB Financial IPO: Why smart money saw 55 times oversubscription but retail held back at 1.4 times bids (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
